{"disease":{"id":"pulmonary-hypertension-due-to-left-heart-disease","name":"pulmonary hypertension due to left heart disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04808596","title":"Pulmonary Hypertension Biorepository and Registry","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University of Kansas Medical Center","has_results":false},{"nct_id":"NCT07537517","title":"Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Hospital General Universitario Gregorio Marañon","has_results":false},{"nct_id":"NCT06048120","title":"A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04484675","title":"Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":38,"lead_sponsor_name":"Zagazig University","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}